echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Microorganisms: Probiotics help inhibit the development of colon cancer.

    Microorganisms: Probiotics help inhibit the development of colon cancer.

    • Last Update: 2020-08-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    20, 2020 /--- new research shows that probiotics can control the development of colorectal cancer (CRC).
    the study was recently published in the journal Microorganisms and was led by Dr Andrew Foey of the University of Pavol Jozef Safarik in Slovakia.
    Foey and his team tested the ability of a mixture of lactic acid bacteria (LAB) strains to affect the activity of immune cells (macrophages) and the on the development of bowel cancer.
    (Photo source: www.pixabay.com) showed that probiotic mixtures partially inhibited tumor occurrence and growth in CRC models.
    researchers concluded that this may be due to the LAB mixture changing the way macrophages behave.
    CRC is the country's fourth most common cancer, the second most common cancer killer, with more than 42,000 people diagnosed with the disease each year in the UK, according to the charity Bowel Cancer UK.
    charity says one in 15 men and one in 18 women will be diagnosed with cancer in their lifetime.
    Foey said: "This study focuses only on understanding CRC and potential treatments for controlling the disease.
    study highlights the positive effects of probiotic mixtures on the CRC-related immune system and their implications for clinical translation studies.
    this highlights the need for future research into probiotics for macrophage response therapy for colorectal cancer in the intestines.
    also indicates the potential use of probiotics in the treatment of tissue-related cancers, such as oral squamous cell carcinoma.
    (bioon.com) Source: Probiotics show to suppress growth of tumours in colorectal cancer Source: Petra Hradicka et al. A Novel Lactic Acid B. B. Partners: Macrophage-Targeted Prophylactic Intervention in ColorIngal Cancer Management, Microorganisms (2020). DOI: 10.3390/microorganisms8030387.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.